Dapagliflozin Tablet
Product Images NDC 70771-1714

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dapagliflozin (NDC 70771-1714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5 mg (E0ce1921 Cd6e 4663 Acd0 Ae34bd8222fa 01)

FDA Label Image

10 mg (E0ce1921 Cd6e 4663 Acd0 Ae34bd8222fa 02)

10 mg (E0ce1921 Cd6e 4663 Acd0 Ae34bd8222fa 02)
This is a description of Dapagliflozin tablets, each containing 10mg of the active ingredient. The recommended dosage instructions are to be followed as per the prescribing information. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with permitted excursions between 15°C and 30°C (59°F and 86°F). The medication guide is available for each patient and should be kept out of reach of children as the packaging is child-resistant. The manufacturer is Zydus Lifesciences Ltd, located in Ahmedabad, India. For more information, the Medication Guide can be found at www.zydususa.com/medguides or by calling 1-677-993-8779.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.